What is the Hyundai Bioland Co., Ltd. stock price forecast?

Hyundai Bioland Co., Ltd. is currently trading at ₩3,665. View real-time AI analysis on Alpha Lenz.

What is Hyundai Bioland Co., Ltd. insider trading activity?

View the latest insider trading data for Hyundai Bioland Co., Ltd. on Alpha Lenz.

What is Hyundai Bioland Co., Ltd.'s P/E ratio?

Hyundai Bioland Co., Ltd.'s P/E ratio is 445.3.

Hyundai Bioland Co., Ltd.

KRX · 052260

₩3,665-85(-2.27%)Market closed

Ask about Hyundai Bioland Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Hyundai Bioland Co., Ltd. trades at a P/E of 445.3 (premium valuation) with modest ROE of 0.2%.”

Ask for details →

Company Overview

Hyundai Bioland Co., Ltd. is a South Korean biotechnology company, primarily engaged in the research, development, and production of bioactive materials. These materials are essential across various industries, including cosmetics, pharmaceuticals, and healthcare products. Hyundai Bioland specializes in creating innovative ingredients derived from natural sources, focusing on safety and efficacy. Its product portfolio includes functional food additives, cosmetic ingredients, and API (Active Pharmaceutical Ingredients) for the medical field, making it a significant player in biotechnological advancements. The company’s contributions to these sectors highlight its role in enhancing product formulations and fostering the development of next-generation bio-based solutions, affirming its prominence in both domestic and global markets.

CEO이희준

Websitehttps://www.hyundaibioland.co.kr

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩112,500,000,000Market Cap

₩130,505,120,700Revenue

30.00MShares Out

0Employees

Margins

41.03%Gross

13.71%EBITDA

9.77%Operating

9.46%Pre-Tax

0.19%Net

Valuation

445.33P/E

0.83P/B

0.86EV/Sales

5.88EV/EBITDA

7.30P/FCF

Growth (CAGR)

9.59%Rev 3Yr

7.98%Rev 5Yr

12.10%Op Inc 3Yr

N/AOp Inc 5Yr

-62.43%Net Inc 3Yr

N/ANet Inc 5Yr

Returns

0.14%ROA

0.18%ROE

7.09%ROIC

Financial Health

₩17,763,206,700Cash & Cash Equivalents

₩12,960,945,030Net Debt

22.57%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Hyundai Bioland Co., Ltd. trades at a P/E of 445.3 (premium valuation) with modest ROE of 0.2%.”

Ask for details →

Frequently Asked Questions

Hyundai Bioland Co., Ltd. (ticker: 052260) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $112.5B.

The current price is ₩3,665 with a P/E ratio of 445.33x and P/B of 0.83x.

ROE is 0.18% and operating margin is 9.77%. Annual revenue is $130.5B.